Recent Quarter Total Invested
$3.21 B
Recent Quarter Institutional Ownership Percentage
72.8%
Total Invested of Last Quarter
$4.08 B
Ownership Percentage of Last Quarter
71.53%
CRISPR Therapeutics AG Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CAPITAL INTERNATIONAL INVESTORS | 08/13/2024 | 7.87 M | $424.80 M | 0.36% | 9.62% |
| ARK INVESTMENT MANAGEMENT LLC | 07/26/2024 | 7.78 M | $420.12 M | -4.64% | 9.51% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 07/19/2024 | 3.15 M | $170.21 M | -3.59% | 3.85% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 08/09/2024 | 3.15 M | $169.99 M | -3.59% | 3.85% |
| BLACKROCK INC. | 08/13/2024 | 2.78 M | $150.03 M | 9.09% | 3.40% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2024 | 2.73 M | $147.48 M | 0.97% | 3.34% |
| STATE STREET CORP | 08/14/2024 | 2.39 M | $129.28 M | 60.09% | 2.93% |
| FMR LLC | 08/13/2024 | 2.35 M | $127.09 M | 5.06% | 2.88% |
| VANGUARD GROUP INC | 08/13/2024 | 1.75 M | $94.44 M | 6.83% | 2.14% |
| NEA MANAGEMENT COMPANY, LLC | 08/14/2024 | 1.59 M | $85.76 M | 0.00% | 1.94% |
| ECOR1 CAPITAL, LLC | 08/14/2024 | 1.39 M | $75.03 M | 0.00% | 1.70% |
| SR ONE CAPITAL MANAGEMENT, LP | 08/13/2024 | 1.05 M | $56.65 M | 0.00% | 1.28% |
| LOOMIS SAYLES & CO L P | 08/13/2024 | 1.01 M | $54.35 M | -1.86% | 1.23% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 973,018 | $52.57 M | 7.01% | 1.19% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 950,149 | $51.33 M | 2.05% | 1.16% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 941,550 | $50.85 M | 9.07% | 1.15% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 717,606 | $38.76 M | 7.23% | 0.88% |
| CITADEL ADVISORS LLC | 08/14/2024 | 710,800 | $38.39 M | -14.88% | 0.87% |
| UBS ASSET MANAGEMENT AMERICAS INC | 08/14/2024 | 693,958 | $37.48 M | 528.22% | 0.85% |
| CONTRARIUS INVESTMENT MANAGEMENT LTD | 08/13/2024 | 685,716 | $37.04 M | 2.96% | 0.84% |
| NORGES BANK | 08/14/2024 | 650,208 | $35.12 M | 100.00% | 0.79% |
| BELLEVUE GROUP AG | 08/14/2024 | 617,649 | $33.36 M | -0.37% | 0.76% |
| MORGAN STANLEY | 08/14/2024 | 597,679 | $32.28 M | -44.96% | 0.73% |
| FARALLON CAPITAL MANAGEMENT LLC | 08/14/2024 | 530,000 | $28.63 M | 100.00% | 0.65% |
| VERSANT VENTURE MANAGEMENT, LLC | 08/07/2024 | 498,558 | $26.93 M | 0.00% | 0.61% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 480,400 | $25.95 M | -15.05% | 0.59% |
| FEDERATED HERMES, INC. | 08/08/2024 | 447,606 | $24.18 M | 0.00% | 0.55% |
| UBS GROUP AG | 08/14/2024 | 424,216 | $22.91 M | 32.41% | 0.52% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 420,695 | $22.72 M | -29.91% | 0.51% |
| BAILLIE GIFFORD & CO | 07/25/2024 | 405,425 | $21.90 M | 2.40% | 0.50% |
| CITADEL ADVISORS LLC | 08/14/2024 | 371,000 | $20.04 M | -23.57% | 0.45% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 352,000 | $19.01 M | -51.86% | 0.43% |
| JANE STREET GROUP, LLC | 08/15/2024 | 349,931 | $18.90 M | 99.88% | 0.43% |
| JPMORGAN CHASE & CO | 08/12/2024 | 329,069 | $17.77 M | -16.21% | 0.40% |
| TANG CAPITAL MANAGEMENT LLC | 08/14/2024 | 316,500 | $17.09 M | 171.67% | 0.39% |
| CAPITAL ADVISORS INC/OK | 07/31/2024 | 278,006 | $15.02 M | 5.31% | 0.34% |
| SQUAREPOINT OPS LLC | 08/14/2024 | 268,823 | $14.52 M | -1.90% | 0.33% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 265,347 | $14.33 M | 99.96% | 0.32% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 260,821 | $14.09 M | 256.13% | 0.32% |
| NORTHERN TRUST CORP | 08/14/2024 | 233,411 | $12.61 M | -4.06% | 0.29% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 227,599 | $12.29 M | 5.18% | 0.28% |
| CUTTER CAPITAL MANAGEMENT, LP | 08/14/2024 | 201,497 | $10.88 M | 67.66% | 0.25% |
| ARMISTICE CAPITAL, LLC | 08/14/2024 | 198,357 | $10.71 M | 3.31% | 0.24% |
| VESTMARK ADVISORY SOLUTIONS, INC. | 08/12/2024 | 197,614 | $10.67 M | -20.81% | 0.24% |
| EAGLE HEALTH INVESTMENTS LP | 08/13/2024 | 197,000 | $10.64 M | 0.00% | 0.24% |
| PICTET ASSET MANAGEMENT HOLDING SA | 08/13/2024 | 190,408 | $10.28 M | -40.59% | 0.23% |
| MARSHALL WACE, LLP | 08/14/2024 | 186,591 | $10.08 M | 100.00% | 0.23% |
| PEAK6 INVESTMENTS LLC | 08/14/2024 | 185,800 | $10.04 M | -35.51% | 0.23% |
| RAFFERTY ASSET MANAGEMENT, LLC | 08/13/2024 | 182,561 | $9.86 M | 47.73% | 0.22% |
| SPEAR HOLDINGS RSC LTD | 07/18/2024 | 165,000 | $8.91 M | 0.00% | 0.20% |
CRISPR Therapeutics AGinstitutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CRSP shares?
During the previous two years, 609 institutional investors and hedge funds held shares of CRISPR Therapeutics AG. The most heavily invested institutionals were:
Capital International Investors: 7.87 M
ARK Investment Management LLC: 7.78 M
Sumitomo Mitsui Trust Holdings, Inc.: 3.15 M
Nikko Asset Management Americas, Inc.: 3.15 M
BlackRock Inc.: 2.78 M
T. Rowe Price Investment Management, Inc.: 2.73 M
-
What percentage of CRISPR Therapeutics AG stock is owned by institutional investors?
72.80% of CRISPR Therapeutics AG stock is owned by institutional investors.
-
How much institutional buying is happening at CRSP ?
Institutional investors have bought a total of 62.71 M shares in the last 24 months. This purchase volume represents approximately $3.07 B in transactions.